Malaysia Aims To Boost Economy With Stepped Up Production Of Generic Drugs
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Malaysia's government is projecting that the healthcare industry will contribute significantly more to the country's economy by 2020, and is now promoting the country as an ideal location to manufacture generics
You may also be interested in...
Quintiles Enters Malaysia Clinical Trial Alliance For First Prime Site In Asia
SINGAPORE - Quintiles has entered an alliance with the University Malaya Medical Centre, creating its first clinical trial Prime Site in Asia, which is focused on accelerating drug development
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).